Sirt1 is an NAD+-dependent deacetylase that plays a role in cellular processes such as transcriptional regulation, stress response, longevity and apoptosis. Sirt1 deacetylates histone proteins and certain transcription factors such as p53, CTIP2 (chicken ovalbumin upstream promoter-transcription factor-interacting protein 2), FOXO (forkhead box O) and NF-κB (nuclear factor κB). To identify potential Sirt1-interacting factors, we performed a yeast two-hybrid screen. The screen identified TLE1 (transducin-like enhancer of split-1) as a possible Sirt1-interacting factor, which was then confirmed by co-immunoprecipitation. TLE1 is a non-DNA binding co-repressor for several transcriptional factors including NF-κB. We have demonstrated using co-transfection assays that Sirt1 and TLE1 repress NF-κB activity. The catalytic mutant of Sirt1, Sirt1-H363Y, and the N-terminal Sirt1 fragment (amino acids 1–270) also show similar repression activity, suggesting that the deacetylase activity of Sirt1 may not be critical for its effect on NF-κB activity. Furthermore, analysis in Sirt1-null MEFs (murine embryonic fibroblasts) and HeLa cells stably expressing siRNA (small interfering RNA) specific to Sirt1 or TLE1 demonstrate that both Sirt1 and TLE1 are required for negative regulation of NF-κB activity. Taken together, these results suggest that the interaction between Sirt1 and TLE1 is important for mediating repression of NF-κB activity.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
November 2007
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
October 29 2007
Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor κB-mediated transcription
Hiyaa S. Ghosh;
Hiyaa S. Ghosh
*Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, U.S.A.
Search for other works by this author on:
James V. Spencer;
James V. Spencer
*Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, U.S.A.
Search for other works by this author on:
Bobby Ng;
Bobby Ng
*Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, U.S.A.
Search for other works by this author on:
Michael W. McBurney;
Michael W. McBurney
†Department of Medicine, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6
‡Ottawa Health Research Institute, 725 Parkdale Avenue, Ottawa, ON, Canada K1Y 4E9
§Department of Biochemistry, Microbiology and Immunology, 451 Smyth Road, Ottawa, ON, Canada K1H 8M5
Search for other works by this author on:
Paul D. Robbins
Paul D. Robbins
1
*Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, U.S.A.
1To whom correspondence should be addressed (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 20 2007
Revision Received:
August 03 2007
Accepted:
August 07 2007
Accepted Manuscript online:
August 07 2007
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2007 Biochemical Society
2007
Biochem J (2007) 408 (1): 105–111.
Article history
Received:
June 20 2007
Revision Received:
August 03 2007
Accepted:
August 07 2007
Accepted Manuscript online:
August 07 2007
Citation
Hiyaa S. Ghosh, James V. Spencer, Bobby Ng, Michael W. McBurney, Paul D. Robbins; Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor κB-mediated transcription. Biochem J 15 November 2007; 408 (1): 105–111. doi: https://doi.org/10.1042/BJ20070817
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |